{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:37:38Z","timestamp":1791488258056,"version":"4.3.4"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/nrneph.2017.34","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T09:13:36Z","timestamp":1489396416000},"page":"329-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["T cells and autoimmune kidney disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Abel","family":"Su\u00e1rez-Fueyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Klatzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"BFnrneph201734_CR1","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.immuni.2016.04.017","volume":"44","author":"Q Zhang","year":"2016","unstructured":"Zhang, Q. & Vignali, D. A. A. Co-stimulatory and co-inhibitory pathways in autoimmunity. Immunity 44, 1034\u20131051 (2016).","journal-title":"Immunity"},{"key":"BFnrneph201734_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneph.2016.18","volume":"12","author":"SR Holdsworth","year":"2016","unstructured":"Holdsworth, S. R., Gan, P.-Y. & Kitching, A. R. Biologics for the treatment of autoimmune renal diseases. Nat. Rev. Nephrol. 12, 217\u2013231 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201734_CR3","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos, G. C. Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110\u20132121 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201734_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molimm.2015.07.003","volume":"68","author":"P Ronco","year":"2015","unstructured":"Ronco, P. & Debiec, H. Membranous nephropathy: a fairy tale for immunopathologists, nephrologists and patients. Mol. Immunol. 68, 57\u201362 (2015).","journal-title":"Mol. Immunol."},{"key":"BFnrneph201734_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrneph.2011.89","volume":"7","author":"Z Cui","year":"2011","unstructured":"Cui, Z. & Zhao, M.-H. Advances in human antiglomerular basement membrane disease. Nat. Rev. Nephrol. 7, 697\u2013705 (2011).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201734_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"JC Jennette","year":"2014","unstructured":"Jennette, J. C. & Falk, R. J. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat. Rev. Rheumatol. 10, 463\u2013473 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrneph201734_CR7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/art.20862","volume":"52","author":"Z Zhao","year":"2005","unstructured":"Zhao, Z. et al. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum. 52, 522\u2013530 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201734_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/08916939409009538","volume":"19","author":"N Suzuki","year":"1994","unstructured":"Suzuki, N., Otuka, I., Harada, T., Mizushima, Y. & Sakane, T. Preferential adsorption of cationic anti-DNA antibodies with immobilized polyanionic compounds, dextran sulfate. Autoimmunity 19, 105\u2013112 (1994).","journal-title":"Autoimmunity"},{"key":"BFnrneph201734_CR9","doi-asserted-by":"publisher","unstructured":"Mastroianni-Kirsztajn, G., Hornig, N. & Schlumberger, W. Autoantibodies in renal diseases \u2014 clinical significance and recent developments in serological detection. Front. Immunol. http:\/\/dx.doi.org\/10.3389\/fimmu.2015.00221 (2015).","DOI":"10.3389\/fimmu.2015.00221"},{"key":"BFnrneph201734_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molimm.2006.06.010","volume":"44","author":"R Flierman","year":"2007","unstructured":"Flierman, R. & Daha, M. R. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis \u2014 a hypothesis. Mol. Immunol. 44, 133\u2013138 (2007).","journal-title":"Mol. Immunol."},{"key":"BFnrneph201734_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1681\/ASN.2011030304","volume":"23","author":"WG Couser","year":"2012","unstructured":"Couser, W. G. Basic and translational concepts of immune-mediated glomerular diseases. J. Am. Soc. Nephrol. 23, 381\u2013399 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201734_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nri3523","volume":"13","author":"C Kurts","year":"2013","unstructured":"Kurts, C., Panzer, U., Anders, H.-J. & Rees, A. J. The immune system and kidney disease: basic concepts and clinical implications. Nat. Rev. Immunol. 13, 738\u2013753 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph201734_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0272-6386(89)80024-1","volume":"13","author":"E Alexopoulos","year":"1989","unstructured":"Alexopoulos, E., Seron, D., Hartley, R. B., Nolasco, F. & Cameron, J. S. Immune mechanisms in idiopathic membranous nephropathy: the role of the interstitial infiltrates. Am. J. Kidney Dis. 13, 404\u2013412 (1989).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201734_CR14","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1681\/ASN.2012010040","volume":"23","author":"J-E Turner","year":"2012","unstructured":"Turner, J.-E. et al. IL-17A production by renal \u03b3\u03b4 T cells promotes kidney injury in crescentic GN. J. Am. Soc. Nephrol. 23, 1486\u20131495 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201734_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.molmed.2010.06.002","volume":"16","author":"TN Mayadas","year":"2010","unstructured":"Mayadas, T. N., Rosetti, F., Ernandez, T. & Sethi, S. Neutrophils: game changers in glomerulonephritis? Trends Mol. Med. 16, 368\u2013378 (2010).","journal-title":"Trends Mol. Med."},{"key":"BFnrneph201734_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood, C. et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22, 146\u2013153 (2016).","journal-title":"Nat. Med."},{"key":"BFnrneph201734_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrneph.2016.71","volume":"12","author":"S Gupta","year":"2016","unstructured":"Gupta, S. & Kaplan, M. J. The role of neutrophils and NETosis in autoimmune and renal diseases. Nat. Rev. Nephrol. 12, 402\u2013413 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201734_CR18","doi-asserted-by":"publisher","unstructured":"Mistry, P. & Kaplan, M. J. Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin. Immunol. http:\/\/dx.doi.org\/10.1016\/j.clim.2016.08.010 (2016).","DOI":"10.1016\/j.clim.2016.08.010"},{"key":"BFnrneph201734_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrrheum.2016.24","volume":"12","author":"E Boilard","year":"2016","unstructured":"Boilard, E. & Fortin, P. R. Connective tissue diseases: mitochondria drive NETosis and inflammation in SLE. Nat. Rev. Rheumatol. 12, 195\u2013196 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrneph201734_CR20","doi-asserted-by":"publisher","first-page":"157ra141","DOI":"10.1126\/scitranslmed.3004801","volume":"4","author":"AM Campbell","year":"2012","unstructured":"Campbell, A. M., Kashgarian, M. & Shlomchik, M. J. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci. Transl Med. 4, 157ra141 (2012).","journal-title":"Sci. Transl Med."},{"issue":"Suppl. 1","key":"BFnrneph201734_CR21","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1007\/s10875-007-9160-5","volume":"28","author":"SD Rosenzweig","year":"2008","unstructured":"Rosenzweig, S. D. Inflammatory manifestations in chronic granulomatous disease (CGD). J. Clin. Immunol. 28 (Suppl. 1), S67\u2013S72 (2008).","journal-title":"J. Clin. Immunol."},{"key":"BFnrneph201734_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1189\/jlb.4RU0315-081RR","volume":"98","author":"R Spada","year":"2015","unstructured":"Spada, R., Rojas, J. M. & Barber, D. F. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J. Leukoc. Biol. 98, 479\u2013487 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph201734_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","volume":"12","author":"A Davidson","year":"2016","unstructured":"Davidson, A. What is damaging the kidney in lupus nephritis? Nat. Rev. Rheumatol. 12, 143\u2013153 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrneph201734_CR24","first-page":"e206731","volume":"2015","author":"J Chen","year":"2015","unstructured":"Chen, J. et al. Immunoregulation of NKT cells in systemic lupus erythematosus, immunoregulation of NKT cells in systemic lupus erythematosus. J. Immunol. Res. 2015, e206731 (2015).","journal-title":"J. Immunol. Res."},{"key":"BFnrneph201734_CR25","doi-asserted-by":"publisher","first-page":"230ra46","DOI":"10.1126\/scitranslmed.3008146","volume":"6","author":"VM Liarski","year":"2014","unstructured":"Liarski, V. M. et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci. Transl Med. 6, 230ra46 (2014).","journal-title":"Sci. Transl Med."},{"key":"BFnrneph201734_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneph.2016.20","volume":"12","author":"F Hiepe","year":"2016","unstructured":"Hiepe, F. & Radbruch, A. Plasma cells as an innovative target in autoimmune disease with renal manifestations. Nat. Rev. Nephrol. 12, 232\u2013240 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201734_CR27","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.it.2016.07.006","volume":"37","author":"SJ Lalor","year":"2016","unstructured":"Lalor, S. J. & McLoughlin, R. M. Memory \u03b3\u03b4 T cells-newly appreciated protagonists in infection and immunity. Trends Immunol. 37, 690\u2013702 (2016).","journal-title":"Trends Immunol."},{"key":"BFnrneph201734_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1189\/jlb.3RU0914-443R","volume":"97","author":"S Paul","year":"2015","unstructured":"Paul, S., Shilpi & Lal, G. Role of gamma-delta (\u03b3\u03b4) T cells in autoimmunity. J. Leukoc. Biol. 97, 259\u2013271 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneph201734_CR29","doi-asserted-by":"publisher","first-page":"7020","DOI":"10.1073\/pnas.87.18.7020","volume":"87","author":"S Rajagopalan","year":"1990","unstructured":"Rajagopalan, S., Zordan, T., Tsokos, G. C. & Datta, S. K. Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor. Proc. Natl Acad. Sci. USA 87, 7020\u20137024 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201734_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.4430","volume":"235","author":"X Peng","year":"2015","unstructured":"Peng, X. et al. IL-17A produced by both \u03b3\u03b4 T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J. Pathol. 235, 79\u201389 (2015).","journal-title":"J. Pathol."},{"key":"BFnrneph201734_CR31","doi-asserted-by":"publisher","first-page":"14432","DOI":"10.1038\/srep14432","volume":"5","author":"S Yin","year":"2015","unstructured":"Yin, S. et al. Hyperactivation and in situ recruitment of inflammatory V\u03b42 T cells contributes to disease pathogenesis in systemic lupus erythematosus. Sci. Rep. 5, 14432 (2015).","journal-title":"Sci. Rep."},{"key":"BFnrneph201734_CR32","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1074\/jbc.M115.700070","volume":"291","author":"H Chen","year":"2016","unstructured":"Chen, H. et al. Chaperonin-containing T-complex protein 1 subunit \u03b6 serves as an autoantigen recognized by human V\u03b42 \u03b3\u03b4 T cells in autoimmune diseases. J. Biol. Chem. 291, 19985\u201319993 (2016).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201734_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1385\/IR:35:1:163","volume":"35","author":"CW Thomson","year":"2006","unstructured":"Thomson, C. W., Lee, B. P.-L. & Zhang, L. Double-negative regulatory T cells: non-conventional regulators. Immunol. Res. 35, 163\u2013178 (2006).","journal-title":"Immunol. Res."},{"key":"BFnrneph201734_CR34","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.4049\/jimmunol.1402775","volume":"194","author":"N Rodr\u00edguez-Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez-Rodr\u00edguez, N. et al. Programmed cell death 1 and Helios distinguish TCR-\u03b1\u03b2+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells. J. Immunol. 194, 4207\u20134214 (2015).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR35","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crisp\u00edn","year":"2008","unstructured":"Crisp\u00edn, J. C. et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181, 8761\u20138766 (2008).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR36","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","volume":"116","author":"JB Oliveira","year":"2010","unstructured":"Oliveira, J. B. et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 116, e35\u2013e40 (2010).","journal-title":"Blood"},{"key":"BFnrneph201734_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2014.01.030","volume":"51","author":"A Alunno","year":"2014","unstructured":"Alunno, A. et al. CD4\u2212CD8\u2212 T-cells in primary Sj\u00f6gren's syndrome: association with the extent of glandular involvement. J. Autoimmun. 51, 38\u201343 (2014).","journal-title":"J. Autoimmun."},{"key":"BFnrneph201734_CR38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s10875-014-0038-z","volume":"34","author":"JA Tarbox","year":"2014","unstructured":"Tarbox, J. A. et al. Elevated double negative T cells in pediatric autoimmunity. J. Clin. Immunol. 34, 594\u2013599 (2014).","journal-title":"J. Clin. Immunol."},{"key":"BFnrneph201734_CR39","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/eji.201546056","volume":"46","author":"N Rodr\u00edguez-Rodr\u00edguez","year":"2016","unstructured":"Rodr\u00edguez-Rodr\u00edguez, N. et al. Pro-inflammatory self-reactive T cells are found within murine TCR-\u03b1\u03b2+ CD4\u2212 CD8\u2212 PD-1+ cells. Eur. J. Immunol. 46, 1383\u20131391 (2016).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneph201734_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00005-015-0362-x","volume":"63","author":"T Yamagata","year":"2015","unstructured":"Yamagata, T., Skepner, J. & Yang, J. Targeting Th17 effector cytokines for the treatment of autoimmune diseases. Arch. Immunol. Ther. Exp. (Warsz.) 63, 405\u2013414 (2015).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"BFnrneph201734_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585\u2013600 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph201734_CR42","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ki.2010.102","volume":"77","author":"J-E Turner","year":"2010","unstructured":"Turner, J.-E., Paust, H.-J., Steinmetz, O. M. & Panzer, U. The Th17 immune response in renal inflammation. Kidney Int. 77, 1070\u20131075 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph201734_CR43","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.4049\/jimmunol.0902999","volume":"184","author":"C Deteix","year":"2010","unstructured":"Deteix, C. et al. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J. Immunol. 184, 5344\u20135351 (2010).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR44","doi-asserted-by":"publisher","first-page":"14292","DOI":"10.1073\/pnas.1009234107","volume":"107","author":"M Mitsdoerffer","year":"2010","unstructured":"Mitsdoerffer, M. et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl Acad. Sci. USA 107, 14292\u201314297 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201734_CR45","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/eji.201445064","volume":"45","author":"H Schaffert","year":"2015","unstructured":"Schaffert, H. et al. IL-17-producing CD4+ T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis. Eur. J. Immunol. 45, 1339\u20131347 (2015).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneph201734_CR46","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.immuni.2016.10.020","volume":"45","author":"CF Krebs","year":"2016","unstructured":"Krebs, C. F. et al. Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney. Immunity 45, 1078\u20131092 (2016).","journal-title":"Immunity"},{"key":"BFnrneph201734_CR47","doi-asserted-by":"publisher","first-page":"F1663","DOI":"10.1152\/ajprenal.00683.2011","volume":"302","author":"J Velden","year":"2012","unstructured":"Velden, J. et al. Renal IL-17 expression in human ANCA-associated glomerulonephritis. Am. J. Physiol. Renal Physiol. 302, F1663\u2013F1673 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201734_CR48","doi-asserted-by":"publisher","unstructured":"Koga, T., Ichinose, K. & Tsokos, G. C. T cells and IL-17 in lupus nephritis. Clin. Immunol. http:\/\/dx.doi.org\/10.1016\/j.clim.2016.04.010 (2016).","DOI":"10.1016\/j.clim.2016.04.010"},{"key":"BFnrneph201734_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4049\/jimmunol.1501831","volume":"197","author":"CF Krebs","year":"2016","unstructured":"Krebs, C. F. et al. Plasticity of Th17 cells in autoimmune kidney diseases. J. Immunol. 197, 449\u2013457 (2016).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/path.4559","volume":"237","author":"S H\u00fcnem\u00f6rder","year":"2015","unstructured":"H\u00fcnem\u00f6rder, S. et al. TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis. J. Pathol. 237, 62\u201371 (2015).","journal-title":"J. Pathol."},{"key":"BFnrneph201734_CR51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrrheum.2012.58","volume":"8","author":"JE Craft","year":"2012","unstructured":"Craft, J. E. Follicular helper T cells in immunity and systemic autoimmunity. Nat. Rev. Rheumatol. 8, 337\u2013347 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrneph201734_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coi.2016.08.003","volume":"43","author":"H Ueno","year":"2016","unstructured":"Ueno, H. T follicular helper cells in human autoimmunity. Curr. Opin. Immunol. 43, 24\u201331 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrneph201734_CR53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita, R. et al. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34, 108\u2013121 (2011).","journal-title":"Immunity"},{"key":"BFnrneph201734_CR54","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","volume":"39","author":"M Locci","year":"2013","unstructured":"Locci, M. et al. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39, 758\u2013769 (2013).","journal-title":"Immunity"},{"key":"BFnrneph201734_CR55","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.4049\/jimmunol.0802626","volume":"183","author":"OM Steinmetz","year":"2009","unstructured":"Steinmetz, O. M. et al. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J. Immunol. 183, 4693\u20134704 (2009).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR56","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1681\/ASN.2015020203","volume":"27","author":"H-J Paust","year":"2016","unstructured":"Paust, H.-J. et al. CXCR3+ regulatory T cells control TH1 responses in crescentic GN. J. Am. Soc. Nephrol. 27, 1933\u20131942 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201734_CR57","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.4049\/jimmunol.175.11.7185","volume":"175","author":"S Shimizu","year":"2005","unstructured":"Shimizu, S. et al. Membranous glomerulonephritis development with Th2-type immune deviations in MRL\/lpr mice deficient for IL-27 receptor (WSX-1). J. Immunol. 175, 7185\u20137192 (2005).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR58","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1002\/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6","volume":"44","author":"K Masutani","year":"2001","unstructured":"Masutani, K. et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum. 44, 2097\u20132106 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201734_CR59","doi-asserted-by":"publisher","first-page":"7917","DOI":"10.3390\/ijms16047917","volume":"16","author":"DYH Yap","year":"2015","unstructured":"Yap, D. Y. H. & Lai, K. N. Pathogenesis of renal disease in systemic lupus erythematosus \u2014 the role of autoantibodies and lymphocytes subset abnormalities. Int. J. Mol. Sci. 16, 7917\u20137931 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"BFnrneph201734_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0192623311430693","volume":"40","author":"RA Peterson","year":"2012","unstructured":"Peterson, R. A. Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol. Pathol. 40, 186\u2013204 (2012).","journal-title":"Toxicol. Pathol."},{"key":"BFnrneph201734_CR61","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.autrev.2015.11.008","volume":"15","author":"C Ferretti","year":"2016","unstructured":"Ferretti, C. & La Cava, A. Adaptive immune regulation in autoimmune diabetes. Autoimmun. Rev. 15, 236\u2013241 (2016).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneph201734_CR62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/nep.12574","volume":"21","author":"JR Ghali","year":"2016","unstructured":"Ghali, J. R., Wang, Y. M., Holdsworth, S. R. & Kitching, A. R. Regulatory T cells in immune-mediated renal disease. Nephrology (Carlton) 21, 86\u201396 (2016).","journal-title":"Nephrology (Carlton)"},{"key":"BFnrneph201734_CR63","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nri3823","volume":"15","author":"D Klatzmann","year":"2015","unstructured":"Klatzmann, D. & Abbas, A. K. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 15, 283\u2013294 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph201734_CR64","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/MNH.0000000000000269","volume":"25","author":"S Chandran","year":"2016","unstructured":"Chandran, S. & Feng, S. Current status of tolerance in kidney transplantation. Curr. Opin. Nephrol. Hypertens. 25, 591\u2013601 (2016).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph201734_CR65","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.molmed.2016.07.003","volume":"22","author":"IR Kasper","year":"2016","unstructured":"Kasper, I. R., Apostolidis, S. A., Sharabi, A. & Tsokos, G. C. Empowering regulatory T cells in autoimmunity. Trends Mol. Med. 22, 784\u2013797 (2016).","journal-title":"Trends Mol. Med."},{"key":"BFnrneph201734_CR66","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.autrev.2016.02.014","volume":"15","author":"D Roccatello","year":"2016","unstructured":"Roccatello, D. et al. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: a prospective study and a review of the literature. Autoimmun. Rev. 15, 529\u2013538 (2016).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneph201734_CR67","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","volume":"365","author":"D Saadoun","year":"2011","unstructured":"Saadoun, D. et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N. Engl. J. Med. 365, 2067\u20132077 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201734_CR68","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","volume":"162","author":"N Arpaia","year":"2015","unstructured":"Arpaia, N. et al. A distinct function of regulatory T cells in tissue protection. Cell 162, 1078\u20131089 (2015).","journal-title":"Cell"},{"key":"BFnrneph201734_CR69","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1073\/pnas.1605081113","volume":"113","author":"D Comte","year":"2016","unstructured":"Comte, D. et al. Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 113, 9321\u20139326 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201734_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1681\/ASN.2015121356","volume":"28","author":"J Chang","year":"2017","unstructured":"Chang, J. et al. CD8+ T cells effect glomerular injury in experimental anti-myeloperoxidase GN. J. Am. Soc. Nephrol. 28, 47\u201355 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201734_CR71","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.2130","volume":"16","author":"EF McKinney","year":"2010","unstructured":"McKinney, E. F. et al. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat. Med. 16, 586\u2013591 (2010).","journal-title":"Nat. Med."},{"key":"BFnrneph201734_CR72","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13075-015-0600-y","volume":"17","author":"K Kopetschke","year":"2015","unstructured":"Kopetschke, K. et al. The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers. Arthritis Res. Ther. 17, 94 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrneph201734_CR73","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nm.3883","volume":"21","author":"CO Park","year":"2015","unstructured":"Park, C. O. & Kupper, T. S. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat. Med. 21, 688\u2013697 (2015).","journal-title":"Nat. Med."},{"key":"BFnrneph201734_CR74","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-2249.2004.02473.x","volume":"136","author":"G Zhou","year":"2004","unstructured":"Zhou, G. et al. Identification of systemically expanded activated T cell clones in MRL\/lpr and NZB\/W F1 lupus model mice. Clin. Exp. Immunol. 136, 448\u2013455 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph201734_CR75","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1002\/1529-0131(200012)43:12<2712::AID-ANR11>3.0.CO;2-T","volume":"43","author":"T Kato","year":"2000","unstructured":"Kato, T. et al. Analysis of accumulated T cell clonotypes in patients with systemic lupus erythematosus. Arthritis Rheum. 43, 2712\u20132721 (2000).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201734_CR76","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s11427-016-5030-9","volume":"59","author":"S-Y Hu","year":"2016","unstructured":"Hu, S.-Y. et al. T cell infiltration is associated with kidney injury in patients with anti-glomerular basement membrane disease. Sci. China Life Sci. 59, 1282\u20131289 (2016).","journal-title":"Sci. China Life Sci."},{"key":"BFnrneph201734_CR77","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1681\/ASN.2015101077","volume":"27","author":"J-H Riedel","year":"2016","unstructured":"Riedel, J.-H. et al. IL-17F promotes tissue injury in autoimmune kidney diseases. J. Am. Soc. Nephrol. 27, 3666\u20133677 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201734_CR78","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000353102","volume":"38","author":"M Ifuku","year":"2013","unstructured":"Ifuku, M. et al. Various roles of Th cytokine mRNA expression in different forms of glomerulonephritis. Am. J. Nephrol. 38, 115\u2013123 (2013).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph201734_CR79","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/art.38955","volume":"67","author":"T Schmidt","year":"2015","unstructured":"Schmidt, T. et al. Function of the Th17\/interleukin-17A immune response in murine lupus nephritis. Arthritis Rheumatol. 67, 475\u2013487 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrneph201734_CR80","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/cmi.2015.105","volume":"13","author":"X Song","year":"2016","unstructured":"Song, X., He, X., Li, X. & Qian, Y. The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity. Cell. Mol. Immunol. 13, 418\u2013431 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"BFnrneph201734_CR81","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1084\/jem.20071258","volume":"205","author":"D Luger","year":"2008","unstructured":"Luger, D. et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205, 799\u2013810 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnrneph201734_CR82","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4049\/jimmunol.1400931","volume":"193","author":"G Amarilyo","year":"2014","unstructured":"Amarilyo, G., Louren\u00e7o, E. V., Shi, F.-D. & La Cava, A. IL-17 promotes murine lupus. J. Immunol. 193, 540\u2013543 (2014).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2009.04031.x","volume":"159","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin. Exp. Immunol. 159, 1\u201310 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph201734_CR84","doi-asserted-by":"publisher","first-page":"e58161","DOI":"10.1371\/journal.pone.0058161","volume":"8","author":"Z Wen","year":"2013","unstructured":"Wen, Z. et al. Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA. PLoS ONE 8, e58161 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneph201734_CR85","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12865-015-0070-7","volume":"16","author":"A Zickert","year":"2015","unstructured":"Zickert, A. et al. IL-17 and IL-23 in lupus nephritis \u2014 association to histopathology and response to treatment. BMC Immunol. 16, 7 (2015).","journal-title":"BMC Immunol."},{"key":"BFnrneph201734_CR86","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.2174\/0929867322666151030163022","volume":"22","author":"JR Ghali","year":"2015","unstructured":"Ghali, J. R., Holdsworth, S. R. & Kitching, A. R. Targeting IL-17 and IL-23 in immune mediated renal disease. Curr. Med. Chem. 22, 4341\u20134365 (2015).","journal-title":"Curr. Med. Chem."},{"key":"BFnrneph201734_CR87","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","volume":"28","author":"W Ouyang","year":"2008","unstructured":"Ouyang, W., Kolls, J. K. & Zheng, Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454\u2013467 (2008).","journal-title":"Immunity"},{"key":"BFnrneph201734_CR88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1681\/ASN.2013101061","volume":"26","author":"EM Disteldorf","year":"2015","unstructured":"Disteldorf, E. M. et al. CXCL5 drives neutrophil recruitment in TH17-mediated GN. J. Am. Soc. Nephrol. 26, 55\u201366 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201734_CR89","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/08916934.2015.1037441","volume":"48","author":"D Li","year":"2015","unstructured":"Li, D. et al. Interleukin-17 in systemic lupus erythematosus: a comprehensive review. Autoimmunity 48, 353\u2013361 (2015).","journal-title":"Autoimmunity"},{"key":"BFnrneph201734_CR90","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.4049\/jimmunol.1502641","volume":"197","author":"B Subbarayal","year":"2016","unstructured":"Subbarayal, B., Chauhan, S. K., Di Zazzo, A. & Dana, R. IL-17 augments B cell activation in ocular surface autoimmunity. J. Immunol. 197, 3464\u20133470 (2016).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR91","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1159\/000430296","volume":"36","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Induction of C-Mip by IL-17 plays an important role in adriamycin-induced podocyte damage. Cell. Physiol. Biochem. 36, 1274\u20131290 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"BFnrneph201734_CR92","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","volume":"43","author":"A Su\u00e1rez-Fueyo","year":"2016","unstructured":"Su\u00e1rez-Fueyo, A., Bradley, S. J. & Tsokos, G. C. T cells in systemic lupus erythematosus. Curr. Opin. Immunol. 43, 32\u201338 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrneph201734_CR93","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/intimm\/dxv067","volume":"28","author":"K Goto","year":"2016","unstructured":"Goto, K. et al. Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis. Int. Immunol. 28, 197\u2013208 (2016).","journal-title":"Int. Immunol."},{"key":"BFnrneph201734_CR94","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.4049\/jimmunol.0902796","volume":"184","author":"L Riol-Blanco","year":"2010","unstructured":"Riol-Blanco, L. et al. IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J. Immunol. 184, 1710\u20131720 (2010).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR95","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.39732","volume":"68","author":"A Reinhardt","year":"2016","unstructured":"Reinhardt, A. et al. Interleukin-23-dependent \u03b3\/\u03b4 T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice. Arthritis Rheumatol. 68, 2476\u20132486 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrneph201734_CR96","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.4049\/jimmunol.0903595","volume":"184","author":"VC Kyttaris","year":"2010","unstructured":"Kyttaris, V. C., Zhang, Z., Kuchroo, V. K., Oukka, M. & Tsokos, G. C. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL\/6-lpr\/lpr mice. J. Immunol. 184, 4605\u20134609 (2010).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR97","doi-asserted-by":"publisher","first-page":"861028","DOI":"10.1155\/2013\/861028","volume":"2013","author":"VC Kyttaris","year":"2013","unstructured":"Kyttaris, V. C., Kampagianni, O. & Tsokos, G. C. Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone mice. BioMed Res. Int. 2013, 861028 (2013).","journal-title":"BioMed Res. Int."},{"key":"BFnrneph201734_CR98","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm.3895","volume":"21","author":"MWL Teng","year":"2015","unstructured":"Teng, M. W. L. et al. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat. Med. 21, 719\u2013729 (2015).","journal-title":"Nat. Med."},{"key":"BFnrneph201734_CR99","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/art.39499","volume":"68","author":"K Ichinose","year":"2016","unstructured":"Ichinose, K. et al. Lupus nephritis IgG induction of calcium\/calmodulin-dependent protein kinase IV expression in podocytes and alteration of their function. Arthritis Rheumatol. 68, 944\u2013952 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrneph201734_CR100","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991\u2013999 (2012).","journal-title":"Nat. Immunol."},{"key":"BFnrneph201734_CR101","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1523-1755.2005.00427.x","volume":"68","author":"MY Huang","year":"2005","unstructured":"Huang, M. Y., Chaturvedi, L. S., Koul, S. & Koul, H. K. Oxalate stimulates IL-6 production in HK-2 cells, a line of human renal proximal tubular epithelial cells. Kidney Int. 68, 497\u2013503 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph201734_CR102","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942\u2013949 (2007).","journal-title":"Nat. Immunol."},{"key":"BFnrneph201734_CR103","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nri.2016.94","volume":"16","author":"H Qi","year":"2016","unstructured":"Qi, H. T follicular helper cells in space-time. Nat. Rev. Immunol. 16, 612\u2013625 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph201734_CR104","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/leu.2014.61","volume":"28","author":"M Jourdan","year":"2014","unstructured":"Jourdan, M. et al. IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors. Leukemia 28, 1647\u20131656 (2014).","journal-title":"Leukemia"},{"key":"BFnrneph201734_CR105","doi-asserted-by":"publisher","first-page":"12239","DOI":"10.1074\/jbc.M413284200","volume":"280","author":"XL Zhang","year":"2005","unstructured":"Zhang, X. L., Topley, N., Ito, T. & Phillips, A. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J. Biol. Chem. 280, 12239\u201312245 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201734_CR106","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/CJI.0b013e318255ada3","volume":"35","author":"G Lin","year":"2012","unstructured":"Lin, G. et al. Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells. J. Immunother. 35, 337\u2013343 (2012).","journal-title":"J. Immunother."},{"key":"BFnrneph201734_CR107","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/ndt\/gfu233","volume":"30","author":"SA Jones","year":"2015","unstructured":"Jones, S. A., Fraser, D. J., Fielding, C. A. & Jones, G. W. Interleukin-6 in renal disease and therapy. Nephrol. Dial. Transplant. 30, 564\u2013574 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201734_CR108","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3109\/0886022X.2010.516857","volume":"32","author":"S-Y Chen","year":"2010","unstructured":"Chen, S.-Y. et al. Effect of IL-6 C-572G polymorphism on idiopathic membranous nephropathy risk in a Han Chinese population. Ren. Fail. 32, 1172\u20131176 (2010).","journal-title":"Ren. Fail."},{"key":"BFnrneph201734_CR109","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/annrheumdis-2016-209668","volume":"76","author":"DJ Wallace","year":"2017","unstructured":"Wallace, D. J. et al. Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial. Ann. Rheum. Dis. 76, 534\u2013542 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201734_CR110","doi-asserted-by":"publisher","first-page":"12993","DOI":"10.1038\/ncomms12993","volume":"7","author":"N Yoshida","year":"2016","unstructured":"Yoshida, N. et al. ICER is requisite for Th17 differentiation. Nat. Commun. 7, 12993 (2016).","journal-title":"Nat. Commun."},{"key":"BFnrneph201734_CR111","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","volume":"259","author":"EM Shevach","year":"2014","unstructured":"Shevach, E. M. & Thornton, A. M. tTregs, pTregs, and iTregs: similarities and differences. Immunol. Rev. 259, 88\u2013102 (2014).","journal-title":"Immunol. Rev."},{"key":"BFnrneph201734_CR112","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/intimm\/dxv045","volume":"27","author":"M Gray","year":"2015","unstructured":"Gray, M. & Gray, D. Regulatory B cells mediate tolerance to apoptotic self in health: implications for disease. Int. Immunol. 27, 505\u2013511 (2015).","journal-title":"Int. Immunol."},{"key":"BFnrneph201734_CR113","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1034\/j.1600-065X.2000.917303.x","volume":"173","author":"A H\u00e4nninen","year":"2000","unstructured":"H\u00e4nninen, A. & Harrison, L. C. Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol. Rev. 173, 109\u2013119 (2000).","journal-title":"Immunol. Rev."},{"key":"BFnrneph201734_CR114","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fimmu.2015.00569","volume":"6","author":"VK Raker","year":"2015","unstructured":"Raker, V. K., Domogalla, M. P. & Steinbrink, K. Tolerogenic dendritic cells for regulatory T cell induction in man. Front. Immunol. 6, 569 (2015).","journal-title":"Front. Immunol."},{"key":"BFnrneph201734_CR115","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.bj.2015.04.001","volume":"38","author":"C Tard","year":"2015","unstructured":"Tard, C., Rouxel, O. & Lehuen, A. Regulatory role of natural killer T cells in diabetes. Biomed. J. 38, 484\u2013495 (2015).","journal-title":"Biomed. J."},{"key":"BFnrneph201734_CR116","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.clim.2012.02.005","volume":"143","author":"SR Hofmann","year":"2012","unstructured":"Hofmann, S. R., R\u00f6sen-Wolff, A., Tsokos, G. C. & Hedrich, C. M. Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin. Immunol. 143, 116\u2013127 (2012).","journal-title":"Clin. Immunol."},{"key":"BFnrneph201734_CR117","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.19082\/1680","volume":"7","author":"SA Zeid","year":"2015","unstructured":"Zeid, S. A., Khalifa, G. & Nabil, M. IL10 in lupus nephritis: detection and relationship with disease activity. Electron. Physician 7, 1680\u20131685 (2015).","journal-title":"Electron. Physician"},{"key":"BFnrneph201734_CR118","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5500\/wjt.v3.i4.91","volume":"3","author":"I Sinuani","year":"2013","unstructured":"Sinuani, I., Beberashvili, I., Averbukh, Z. & Sandbank, J. Role of IL-10 in the progression of kidney disease. World J. Transplant. 3, 91\u201398 (2013).","journal-title":"World J. Transplant."},{"key":"BFnrneph201734_CR119","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","volume":"38","author":"W Liao","year":"2013","unstructured":"Liao, W., Lin, J.-X. & Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13\u201325 (2013).","journal-title":"Immunity"},{"key":"BFnrneph201734_CR120","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/08916934.2016.1217998","volume":"49","author":"Z Parackova","year":"2016","unstructured":"Parackova, Z. et al. T regulatory lymphocytes in type 1 diabetes: impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients. Autoimmunity 49, 523\u2013531 (2016).","journal-title":"Autoimmunity"},{"key":"BFnrneph201734_CR121","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11926-016-0617-5","volume":"18","author":"M Mizui","year":"2016","unstructured":"Mizui, M. & Tsokos, G. C. Low-dose IL-2 in the treatment of lupus. Curr. Rheumatol. Rep. 18, 68 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrneph201734_CR122","doi-asserted-by":"publisher","first-page":"13027","DOI":"10.1038\/ncomms13027","volume":"7","author":"L P\u00e9rol","year":"2016","unstructured":"P\u00e9rol, L. et al. Loss of immune tolerance to IL-2 in type 1 diabetes. Nat. Commun. 7, 13027 (2016).","journal-title":"Nat. Commun."},{"key":"BFnrneph201734_CR123","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1073\/pnas.0903158107","volume":"107","author":"JY Humrich","year":"2010","unstructured":"Humrich, J. Y. et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc. Natl Acad. Sci. USA 107, 204\u2013209 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201734_CR124","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jaut.2012.02.001","volume":"38","author":"R Sharma","year":"2012","unstructured":"Sharma, R., Sung, S.-S. J., Gaskin, F., Fu, S. M. & Ju, S.-T. A novel function of IL-2: chemokine\/chemoattractant\/retention receptor genes induction in Th subsets for skin and lung inflammation. J. Autoimmun. 38, 322\u2013331 (2012).","journal-title":"J. Autoimmun."},{"key":"BFnrneph201734_CR125","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.immuni.2015.08.017","volume":"43","author":"JP Ray","year":"2015","unstructured":"Ray, J. P. et al. The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells. Immunity 43, 690\u2013702 (2015).","journal-title":"Immunity"},{"key":"BFnrneph201734_CR126","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.4049\/jimmunol.1400977","volume":"193","author":"M Mizui","year":"2014","unstructured":"Mizui, M. et al. IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8-IL-17-producing T cells. J. Immunol. 193, 2168\u20132177 (2014).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR127","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11892-016-0807-6","volume":"16","author":"A Spence","year":"2016","unstructured":"Spence, A. & Tang, Q. Restoring regulatory T Cells in type 1 diabetes. Curr. Diab. Rep. 16, 110 (2016).","journal-title":"Curr. Diab. Rep."},{"key":"BFnrneph201734_CR128","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","volume":"365","author":"J Koreth","year":"2011","unstructured":"Koreth, J. et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365, 2055\u20132066 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201734_CR129","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nm.4148","volume":"22","author":"J He","year":"2016","unstructured":"He, J. et al. Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus. Nat. Med. 22, 991\u2013993 (2016).","journal-title":"Nat. Med."},{"key":"BFnrneph201734_CR130","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","volume":"75","author":"C von Spee-Mayer","year":"2016","unstructured":"von Spee-Mayer, C. et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 75, 1407\u20131415 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201734_CR131","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/annrheumdis-2014-206506","volume":"74","author":"JY Humrich","year":"2015","unstructured":"Humrich, J. Y. et al. Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE. Ann. Rheum. Dis. 74, 791\u2013792 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201734_CR132","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","volume":"1","author":"A Hartemann","year":"2013","unstructured":"Hartemann, A. et al. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 1, 295\u2013305 (2013).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"BFnrneph201734_CR133","doi-asserted-by":"publisher","unstructured":"Comte, D. et al. CD4+ T cells from SLE patients respond poorly to exogenous IL-2. Arthritis Rheum. http:\/\/dx.doi.org\/10.1002\/art.40014 (2016).","DOI":"10.1002\/art.40014"},{"key":"BFnrneph201734_CR134","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1172\/JCI78087","volume":"125","author":"VR Moulton","year":"2015","unstructured":"Moulton, V. R. & Tsokos, G. C. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J. Clin. Invest. 125, 2220\u20132227 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201734_CR135","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/08916934.2016.1174855","volume":"49","author":"P Li","year":"2016","unstructured":"Li, P. et al. TCR-CD3\u03b6 gene polymorphisms and expression profile in rheumatoid arthritis. Autoimmunity 49, 466\u2013471 (2016).","journal-title":"Autoimmunity"},{"key":"BFnrneph201734_CR136","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11892-016-0736-4","volume":"16","author":"H Zayed","year":"2016","unstructured":"Zayed, H. Genetic epidemiology of type 1 diabetes in the 22 Arab countries. Curr. Diab. Rep. 16, 37 (2016).","journal-title":"Curr. Diab. Rep."},{"key":"BFnrneph201734_CR137","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1182\/blood-2006-12-064170","volume":"109","author":"Z Zhang","year":"2007","unstructured":"Zhang, Z. et al. TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues. Blood 109, 4328\u20134335 (2007).","journal-title":"Blood"},{"key":"BFnrneph201734_CR138","doi-asserted-by":"publisher","first-page":"509021","DOI":"10.1155\/2010\/509021","volume":"2010","author":"K Yoshimoto","year":"2010","unstructured":"Yoshimoto, K., Setoyama, Y., Tsuzaka, K., Abe, T. & Takeuchi, T. Reduced expression of TCR zeta is involved in the abnormal production of cytokines by peripheral T cells of patients with systemic lupus erythematosus. J. Biomed. Biotechnol. 2010, 509021 (2010).","journal-title":"J. Biomed. Biotechnol."},{"key":"BFnrneph201734_CR139","first-page":"413","volume":"11","author":"G Ferraccioli","year":"2011","unstructured":"Ferraccioli, G. & Zizzo, G. The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. Discov. Med. 11, 413\u2013424 (2011).","journal-title":"Discov. Med."},{"key":"BFnrneph201734_CR140","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.4049\/jimmunol.1300634","volume":"191","author":"G-M Deng","year":"2013","unstructured":"Deng, G.-M., Beltran, J., Chen, C., Terhorst, C. & Tsokos, G. C. T. Cell CD3\u03b6 deficiency enables multiorgan tissue inflammation. J. Immunol. 191, 3563\u20133567 (2013).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR141","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/15419069809010798","volume":"6","author":"RV Sionov","year":"1998","unstructured":"Sionov, R. V. & Naor, D. Calcium- and calmodulin-dependent PMA-activation of the CD44 adhesion molecule. Cell Adhes. Commun. 6, 503\u2013523 (1998).","journal-title":"Cell Adhes. Commun."},{"key":"BFnrneph201734_CR142","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/art.27385","volume":"62","author":"JC Crisp\u00edn","year":"2010","unstructured":"Crisp\u00edn, J. C. et al. Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity. Arthritis Rheum. 62, 1431\u20131437 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201734_CR143","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI42856","volume":"120","author":"PS Biswas","year":"2010","unstructured":"Biswas, P. S. et al. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J. Clin. Invest. 120, 3280\u20133295 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201734_CR144","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.4049\/jimmunol.178.3.1938","volume":"178","author":"Y Li","year":"2007","unstructured":"Li, Y. et al. Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus. J. Immunol. 178, 1938\u20131947 (2007).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR145","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1124\/pr.115.010595","volume":"67","author":"G Loirand","year":"2015","unstructured":"Loirand, G. Rho kinases in health and disease: from basic science to translational research. Pharmacol. Rev. 67, 1074\u20131095 (2015).","journal-title":"Pharmacol. Rev."},{"key":"BFnrneph201734_CR146","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1254\/jphs.FMJ05003X5","volume":"100","author":"T Nishikimi","year":"2006","unstructured":"Nishikimi, T. & Matsuoka, H. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis. J. Pharmacol. Sci. 100, 22\u201328 (2006).","journal-title":"J. Pharmacol. Sci."},{"key":"BFnrneph201734_CR147","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bcp.12196","volume":"76","author":"R Komers","year":"2013","unstructured":"Komers, R. Rho kinase inhibition in diabetic kidney disease. Br. J. Clin. Pharmacol. 76, 551\u2013559 (2013).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BFnrneph201734_CR148","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/art.37934","volume":"65","author":"J Isgro","year":"2013","unstructured":"Isgro, J. et al. Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus. Arthritis Rheum. 65, 1592\u20131602 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201734_CR149","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1254\/jphs.FMJ05003X6","volume":"100","author":"K Hayashi","year":"2006","unstructured":"Hayashi, K. et al. Molecular mechanisms and therapeutic strategies of chronic renal injury: role of rho-kinase in the development of renal injury. J. Pharmacol. Sci. 100, 29\u201333 (2006).","journal-title":"J. Pharmacol. Sci."},{"key":"BFnrneph201734_CR150","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/0961203312436862","volume":"21","author":"RA Stirzaker","year":"2012","unstructured":"Stirzaker, R. A. et al. Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB\/W F1 female mice. Lupus 21, 656\u2013661 (2012).","journal-title":"Lupus"},{"key":"BFnrneph201734_CR151","doi-asserted-by":"publisher","first-page":"F1015","DOI":"10.1152\/ajprenal.00380.2011","volume":"303","author":"C Meyer-Schwesinger","year":"2012","unstructured":"Meyer-Schwesinger, C. et al. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis. Am. J. Physiol. Renal Physiol. 303, F1015\u2013F1025 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201734_CR152","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mce.2013.07.019","volume":"381","author":"X Xie","year":"2013","unstructured":"Xie, X. et al. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA\/ROCK signaling. Mol. Cell. Endocrinol. 381, 56\u201365 (2013).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnrneph201734_CR153","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/cancers7020648","volume":"7","author":"M Kiely","year":"2015","unstructured":"Kiely, M. & Kiely, P. A. PP2A: the wolf in sheep's clothing? Cancers (Basel) 7, 648\u2013669 (2015).","journal-title":"Cancers (Basel)"},{"key":"BFnrneph201734_CR154","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ni.3390","volume":"17","author":"SA Apostolidis","year":"2016","unstructured":"Apostolidis, S. A. et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat. Immunol. 17, 556\u2013564 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrneph201734_CR155","doi-asserted-by":"publisher","first-page":"12443","DOI":"10.1073\/pnas.1103915108","volume":"108","author":"JC Crisp\u00edn","year":"2011","unstructured":"Crisp\u00edn, J. C., Apostolidis, S. A., Finnell, M. I. & Tsokos, G. C. Induction of PP2A B\u03b2, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 108, 12443\u201312448 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201734_CR156","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.4049\/jimmunol.181.5.3658","volume":"181","author":"Y-T Juang","year":"2008","unstructured":"Juang, Y.-T. et al. PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells. J. Immunol. 181, 3658\u20133664 (2008).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR157","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1172\/JCI24895","volume":"115","author":"CG Katsiari","year":"2005","unstructured":"Katsiari, C. G., Kyttaris, V. C., Juang, Y.-T. & Tsokos, G. C. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J. Clin. Invest. 115, 3193\u20133204 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201734_CR158","doi-asserted-by":"publisher","first-page":"14996","DOI":"10.1074\/jbc.M113.533547","volume":"289","author":"R Breuer","year":"2014","unstructured":"Breuer, R. et al. The protein phosphatase 2A regulatory subunit B56\u03b3 mediates suppression of T cell receptor (TCR)-induced nuclear factor-\u03baB (NF-\u03baB) activity. J. Biol. Chem. 289, 14996\u201315004 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201734_CR159","doi-asserted-by":"publisher","first-page":"26775","DOI":"10.1074\/jbc.M113.483743","volume":"288","author":"SA Apostolidis","year":"2013","unstructured":"Apostolidis, S. A., Rauen, T., Hedrich, C. M., Tsokos, G. C. & Crispin, J. C. Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling. J. Biol. Chem. 288, 26775\u201326784 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201734_CR160","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/eji.201545805","volume":"46","author":"F Ottenlinger","year":"2016","unstructured":"Ottenlinger, F. et al. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-\u03b3 production in CD8+ lymphocytes. Eur. J. Immunol. 46, 941\u2013951 (2016).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneph201734_CR161","doi-asserted-by":"publisher","first-page":"21936","DOI":"10.1074\/jbc.M113.467266","volume":"288","author":"K Sunahori","year":"2013","unstructured":"Sunahori, K. et al. The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase\/extracellular signal-regulated kinase (ERK) kinase (MEK)\/phosphorylated ERK\/DNMT1 protein pathway in t-cells from controls and systemic lupus erythematosus patients. J. Biol. Chem. 288, 21936\u201321944 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201734_CR162","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1074\/jbc.M110.166785","volume":"286","author":"Y-T Juang","year":"2011","unstructured":"Juang, Y.-T. et al. Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus. J. Biol. Chem. 286, 1795\u20131801 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201734_CR163","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.4049\/jimmunol.1200143","volume":"188","author":"JC Crisp\u00edn","year":"2012","unstructured":"Crisp\u00edn, J. C. et al. Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism. J. Immunol. 188, 3567\u20133571 (2012).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR164","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.molmed.2013.02.001","volume":"19","author":"T Rauen","year":"2013","unstructured":"Rauen, T., Hedrich, C. M., Tenbrock, K. & Tsokos, G. C. cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol. Med. 19, 262\u2013269 (2013).","journal-title":"Trends Mol. Med."},{"key":"BFnrneph201734_CR165","doi-asserted-by":"publisher","first-page":"16606","DOI":"10.1073\/pnas.1210129109","volume":"109","author":"CM Hedrich","year":"2012","unstructured":"Hedrich, C. M. et al. cAMP response element modulator \u03b1 controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc. Natl Acad. Sci. USA 109, 16606\u201316611 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201734_CR166","doi-asserted-by":"publisher","first-page":"31880","DOI":"10.1074\/jbc.M113.508655","volume":"288","author":"CM Hedrich","year":"2013","unstructured":"Hedrich, C. M. et al. cAMP-responsive element modulator \u03b1 (CREM\u03b1) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease. J. Biol. Chem. 288, 31880\u201331887 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201734_CR167","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1074\/jbc.M113.523605","volume":"289","author":"CM Hedrich","year":"2014","unstructured":"Hedrich, C. M. et al. cAMP responsive element modulator (CREM) mediates chromatin remodeling of CD8 during the generation of CD3+CD4-CD8- T cells. J. Biol. Chem. 289, 2361\u20132370 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201734_CR168","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pbiomolbio.2015.12.016","volume":"121","author":"H Naz","year":"2016","unstructured":"Naz, H., Islam, A., Ahmad, F. & Hassan, M. I. Calcium\/calmodulin-dependent protein kinase IV: a multifunctional enzyme and potential therapeutic target. Prog. Biophys. Mol. Biol. 121, 54\u201365 (2016).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"BFnrneph201734_CR169","doi-asserted-by":"publisher","first-page":"31809","DOI":"10.1074\/jbc.272.50.31809","volume":"272","author":"SI Gringhuis","year":"1997","unstructured":"Gringhuis, S. I., de Leij, L. F., Wayman, G. A., Tokumitsu, H. & Vellenga, E. The Ca2+\/calmodulin-dependent kinase type IV is involved in the CD5-mediated signaling pathway in human T lymphocytes. J. Biol. Chem. 272, 31809\u201331820 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201734_CR170","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1172\/JCI22854","volume":"115","author":"Y-T Juang","year":"2005","unstructured":"Juang, Y.-T. et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J. Clin. Invest. 115, 996\u20131005 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201734_CR171","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.4049\/jimmunol.1201785","volume":"189","author":"T Koga","year":"2012","unstructured":"Koga, T., Ichinose, K., Mizui, M., Crisp\u00edn, J. C. & Tsokos, G. C. Calcium\/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus. J. Immunol. 189, 3490\u20133496 (2012).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR172","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI73411","volume":"124","author":"T Koga","year":"2014","unstructured":"Koga, T. et al. CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance. J. Clin. Invest. 124, 2234\u20132245 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201734_CR173","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/art.39665","volume":"68","author":"T Koga","year":"2016","unstructured":"Koga, T. et al. CaMK4 facilitates the recruitment of IL-17-producing cells to target organs through the CCR6\/CCL20 axis in Th17-driven inflammatory diseases. Arthritis Rheumatol. 68, 1981\u20131988 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrneph201734_CR174","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/08916934.2014.915954","volume":"47","author":"T Koga","year":"2014","unstructured":"Koga, T. et al. KN-93, an inhibitor of calcium\/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3+ regulatory T cells in MRL\/lpr mice. Autoimmunity 47, 445\u2013450 (2014).","journal-title":"Autoimmunity"},{"key":"BFnrneph201734_CR175","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.4049\/jimmunol.1102357","volume":"187","author":"K Ichinose","year":"2011","unstructured":"Ichinose, K. et al. Cutting edge: calcium\/calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis. J. Immunol. 187, 5500\u20135504 (2011).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR176","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"A Perl","year":"2016","unstructured":"Perl, A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat. Rev. Rheumatol. 12, 169\u2013182 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrneph201734_CR177","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11926-016-0615-7","volume":"18","author":"S-C Choi","year":"2016","unstructured":"Choi, S.-C., Titov, A. A., Sivakumar, R., Li, W. & Morel, L. Immune cell metabolism in systemic lupus erythematosus. Curr. Rheumatol. Rep. 18, 66 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrneph201734_CR178","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","volume":"12","author":"GM Delgoffe","year":"2011","unstructured":"Delgoffe, G. M. et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12, 295\u2013303 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrneph201734_CR179","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","volume":"192","author":"H Kato","year":"2014","unstructured":"Kato, H. & Perl, A. Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8-double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus. J. Immunol. 192, 4134\u20134144 (2014).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR180","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.4049\/jimmunol.1101602","volume":"187","author":"A Su\u00e1rez-Fueyo","year":"2011","unstructured":"Su\u00e1rez-Fueyo, A., Barber, D. F., Mart\u00ednez-Ara, J., Zea-Mendoza, A. C. & Carrera, A. C. Enhanced phosphoinositide 3-kinase \u03b4 activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death. J. Immunol. 187, 2376\u20132385 (2011).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR181","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.4049\/jimmunol.1400044","volume":"193","author":"S Kshirsagar","year":"2014","unstructured":"Kshirsagar, S. et al. Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis. J. Immunol. 193, 4895\u20134903 (2014).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR182","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","volume":"191","author":"Z-W Lai","year":"2013","unstructured":"Lai, Z.-W. et al. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. J. Immunol. 191, 2236\u20132246 (2013).","journal-title":"J. Immunol."},{"key":"BFnrneph201734_CR183","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","volume":"18","author":"Z Oaks","year":"2016","unstructured":"Oaks, Z., Winans, T., Huang, N., Banki, K. & Perl, A. Activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years. Curr. Rheumatol. Rep. 18, 73 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrneph201734_CR184","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.it.2014.10.006","volume":"36","author":"D Saleiro","year":"2015","unstructured":"Saleiro, D. & Platanias, L. C. Intersection of mTOR and STAT signaling in immunity. Trends Immunol. 36, 21\u201329 (2015).","journal-title":"Trends Immunol."},{"key":"BFnrneph201734_CR185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916930601095148","volume":"40","author":"T Harada","year":"2007","unstructured":"Harada, T. et al. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 40, 1\u20138 (2007).","journal-title":"Autoimmunity"},{"key":"BFnrneph201734_CR186","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/art.39535","volume":"68","author":"G Yiu","year":"2016","unstructured":"Yiu, G. et al. Development of Th17-associated interstitial kidney inflammation in lupus-prone mice lacking the gene encoding STAT-1. Arthritis Rheumatol. 68, 1233\u20131244 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrneph201734_CR187","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1084\/jem.20130731","volume":"210","author":"Y Ge","year":"2013","unstructured":"Ge, Y. et al. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J. Exp. Med. 210, 2387\u20132401 (2013).","journal-title":"J. Exp. Med."},{"key":"BFnrneph201734_CR188","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/gene.2012.57","volume":"14","author":"C Xie","year":"2013","unstructured":"Xie, C. et al. Lupus-prone strains vary in susceptibility to antibody-mediated end organ disease. Genes Immun. 14, 170\u2013178 (2013).","journal-title":"Genes Immun."},{"key":"BFnrneph201734_CR189","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1172\/JCI36728","volume":"119","author":"K Liu","year":"2009","unstructured":"Liu, K. et al. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J. Clin. Invest. 119, 911\u2013923 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201734_CR190","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1093\/ndt\/gfn314","volume":"23","author":"T Arakawa","year":"2008","unstructured":"Arakawa, T. et al. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis. Nephrol. Dial. Transplant. 23, 3418\u20133426 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201734_CR191","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1681\/ASN.2010040352","volume":"22","author":"C Velagapudi","year":"2011","unstructured":"Velagapudi, C. et al. The tuberin\/mTOR pathway promotes apoptosis of tubular epithelial cells in diabetes. J. Am. Soc. Nephrol. 22, 262\u2013273 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201734_CR192","doi-asserted-by":"publisher","first-page":"317682","DOI":"10.1155\/2013\/317682","volume":"2013","author":"S Yung","year":"2013","unstructured":"Yung, S., Cheung, K. F., Zhang, Q. & Chan, T. M. Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis. Clin. Dev. Immunol. 2013, 317682 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"BFnrneph201734_CR193","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1002\/art.38174","volume":"65","author":"J Zhao","year":"2013","unstructured":"Zhao, J. et al. P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3\/ASC\/caspase 1 pathway. Arthritis Rheum. 65, 3176\u20133185 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201734_CR194","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/art.38993","volume":"67","author":"J Zhao","year":"2015","unstructured":"Zhao, J. et al. Lupus nephritis: glycogen synthase kinase 3\u03b2 promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice. Arthritis Rheumatol. 67, 1036\u20131044 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrneph201734_CR195","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/ki.1996.298","volume":"50","author":"PS Benz","year":"1996","unstructured":"Benz, P. S., Fan, X. & W\u00fcthrich, R. P. Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis. Kidney Int. 50, 156\u2013163 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph201734_CR196","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1073\/pnas.1525086113","volume":"113","author":"HF Kuipers","year":"2016","unstructured":"Kuipers, H. F. et al. Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc. Natl Acad. Sci. USA 113, 1339\u20131344 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201734_CR197","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1172\/JCI79271","volume":"125","author":"N Nagy","year":"2015","unstructured":"Nagy, N. et al. Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis. J. Clin. Invest. 125, 3928\u20133940 (2015).","journal-title":"J. Clin. Invest."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2017.34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2017.34","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrneph.2017.34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2017.34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T23:12:02Z","timestamp":1719097922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":197,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFnrneph201734"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2017.34","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]},"assertion":[{"value":"13 March 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}